Cupric Chloride Dihydrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09131 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | thrombocytopenia due to immune destruction | KG + DL |
| 4 | renal osteodystrophy | KG + DL |
| 5 | Glanzmann thrombasthenia | KG + DL |
| 6 | severe nonproliferative diabetic retinopathy | KG + DL |
| 7 | impaired renal function disease | KG + DL |
| 8 | non-syndromic esophageal malformation | KG + DL |
| 9 | non-renal secondary hyperparathyroidism | KG + DL |
| 10 | bone remodeling disease | KG + DL |
| 11 | hyperparathyroidism, transient neonatal | KG + DL |
| 12 | diabetic retinopathy | KG + DL |
| 13 | vitamin A deficiency (disease) | KG + DL |
| 14 | neonatal thrombocytopenia | KG + DL |
| 15 | autoimmune thrombocytopenic | KG + DL |
| 16 | esophageal disease | KG + DL |
| 17 | hypophosphatemic rickets | KG + DL |
| 18 | burn | KG + DL |
| 19 | renal tubular acidosis | KG + DL |
| 20 | autosomal thrombocytopenia with normal platelets | KG + DL |
| 21 | hypocalcemic rickets | KG + DL |
| 22 | bone fracture | KG + DL |
| 23 | ankle injury | KG + DL |
| 24 | spinal injury | KG + DL |
| 25 | vitamin B deficiency | KG + DL |
| 26 | congenital prothrombin deficiency | KG + DL |
| 27 | scurvy | KG + DL |
| 28 | vitamin K deficiency hemorrhagic disease | KG + DL |
| 29 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.